Global production capacity of seasonal influenza vaccine in 2011.
about
Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature reviewA global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunizationVaccine procurement during an influenza pandemic and the role of Advance Purchase Agreements: Lessons from 2009-H1N1.Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesSeasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.Influenza vaccines: an Asia-Pacific perspective.One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.Considerations for the rapid deployment of vaccines against H7N9 influenza.Current and emerging cell culture manufacturing technologies for influenza vaccines.The 2015 global production capacity of seasonal and pandemic influenza vaccineEffects of green tea gargling on the prevention of influenza infection in high school students: a randomized controlled studySeasonal influenza and vaccine herd effect.Plant-based vaccines against viruses.Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?Effect of gargling with tea and ingredients of tea on the prevention of influenza infection: a meta-analysis.Semiconductor diode laser device adjuvanting intradermal vaccine.Influenza vaccines: unmet needs and recent developments.Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.Cell-culture derived fowl adenovirus serotype 4 inactivated vaccine provides complete protection for virus infection on SPF chickens.Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production.International meeting on influenza vaccine effectiveness, 3-4 December 2012, Geneva, Switzerland.Purification of modified vaccinia virus Ankara from suspension cell culture.Cell culture-derived flu vaccine: Present and future.Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries.
P2860
Q26769664-17D09F8A-FF5C-4D4A-B86D-087568F76FDAQ28078555-1B1099C7-E35E-47D8-925E-AF8C46D508B2Q30203064-1C13FDE0-87F0-4280-BE4D-9E23EB804AF3Q30209342-D3DA5809-C401-4F4E-A3DC-BD71CE0239C6Q30218410-D4A8C8E5-CC69-41D3-A757-9D6FC787751FQ30355443-17801436-58C8-4D5D-A010-56200D353740Q30355863-1DE618A5-C458-488A-A900-66876E06B766Q30364635-1662583E-3256-4B40-9D94-FABB5C3C052FQ30373128-D041FB55-F267-46BF-B6C2-A227535108D0Q30391889-3871ACEF-B41F-4E4F-8FB4-4F85660C5D8DQ33623705-ADE08F91-E2D5-4F46-AF04-CE9923EF75C4Q33850478-47FB0A07-A473-4C4B-B7AB-00C81A03124AQ34687464-989284C2-3EF5-446D-81CE-FA25A01C7C60Q35076802-28B2AB5D-AC99-46E3-8B40-B1A779E93075Q35085391-41EF50D3-DFF5-496B-9620-24E9CD3DB4C4Q36016798-F36DD33D-88B2-49A8-A786-1821760F50ADQ36330880-089AEEE2-7A24-4C1B-A9D5-7DAD4AC6D9DCQ37518273-90E66B4F-0F00-4C62-B754-7302DEE924E4Q38204774-1D34D96C-CF15-4A82-B631-F0B0A40A1468Q40097049-027F7BC6-380F-4429-AB8A-56B90B7EF0FBQ40589261-5948EFA3-76C6-4B34-8D25-7C339A7A1AADQ40766700-A188B191-0788-47C2-8D43-EBFC6EB43487Q42696030-9ED77635-65AA-4FA6-8D7E-86C6AB9F3876Q46251065-D7EB8E54-6A5D-4A81-A57D-9CFA6467E265Q52315669-8BF3AEB9-641D-4655-9A6E-79196079538FQ55425122-AD86F53D-61DC-4377-B797-7846ECED3C2D
P2860
Global production capacity of seasonal influenza vaccine in 2011.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Global production capacity of seasonal influenza vaccine in 2011.
@ast
Global production capacity of seasonal influenza vaccine in 2011.
@en
type
label
Global production capacity of seasonal influenza vaccine in 2011.
@ast
Global production capacity of seasonal influenza vaccine in 2011.
@en
prefLabel
Global production capacity of seasonal influenza vaccine in 2011.
@ast
Global production capacity of seasonal influenza vaccine in 2011.
@en
P1433
P1476
Global production capacity of seasonal influenza vaccine in 2011.
@en
P2093
Jeffrey Partridge
P304
P356
10.1016/J.VACCINE.2012.10.111
P407
P577
2012-11-10T00:00:00Z